Mineral deficiencies

NanoVeda Unveils Rapid Dissolve Nutrition Strips to American Consumers

Retrieved on: 
Wednesday, July 7, 2021
Mineral deficiencies, Ayurveda, Massage therapy, Pseudoscience, Vedic period, Iron deficiency, Digestion, Medicine, Branches of biology, Biology

PALM BEACH, FL, July 07, 2021 (GLOBE NEWSWIRE) -- American consumers looking for organic and plant-based nutrition now have access to NanoVedas revolutionary products, which combine Swiss nanotechnology with traditional Ayurveda remedies.

Key Points: 
  • PALM BEACH, FL, July 07, 2021 (GLOBE NEWSWIRE) -- American consumers looking for organic and plant-based nutrition now have access to NanoVedas revolutionary products, which combine Swiss nanotechnology with traditional Ayurveda remedies.
  • We developed rapid dissolve oral strips with Swiss nanotechnology that turns the nutritional ingredients into fine particles for faster, more effective absorption, said Rakshit Mehta, founder of the Swiss-based NanoVeda health and wellness company.
  • Nanoveda developed rapid dissolve oral strips for people with sleep issues, fatigue, iron deficiency, stress, digestion problems, and weakened immune systems.
  • The Swiss company will continue adding retail outlets in 2021 to make it easy for American consumers to find its nutritional products.

Lucky Iron Fish receives $250k in funding to help address iron deficiency anemia in Benin.

Retrieved on: 
Wednesday, June 30, 2021
Mineral deficiencies, Nutrition, Chemistry, Iron metabolism, Physical sciences, Iron-deficiency anemia, Lucky iron fish, Iron deficiency, Iron, Anemia

Toronto, June 30, 2021 (GLOBE NEWSWIRE) -- Lucky Iron Fish Enterprise (LIFe) is an impact-driven company that is on a mission to tackle iron deficiency globally using their innovative solutions designed to make iron intake more accessible to more people.

Key Points: 
  • Toronto, June 30, 2021 (GLOBE NEWSWIRE) -- Lucky Iron Fish Enterprise (LIFe) is an impact-driven company that is on a mission to tackle iron deficiency globally using their innovative solutions designed to make iron intake more accessible to more people.
  • For this project, LIFe will be working with their long-termpartners at CARE Benin .With the help of the $250,000 funding, they will provide nutrition workshops and introduce the Lucky Iron Fish as a recommended addition to daily cooking in order to reduce prevalence of iron deficiency anemia.
  • Iron deficiency is a global health issue that impacts 1 out of 3 individuals (2+ billion worldwide), with women, girls, and children impacted at a disproportionately higher rate.
  • In Benin alone, 62% of children under 5 and 47% of females of reproductive age suffer from iron deficiency anemia.

Rockwell Medical, Inc. Files Pre-IND Meeting Request with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion

Retrieved on: 
Monday, June 28, 2021
Medical specialties, Blood, Clinical medicine, Intravenous fluids, Anemias, Mineral deficiencies, Intensive care medicine, Parenteral nutrition, Iron deficiency, Rockwell Medical

Many patient groups requiring home infusion therapies suffer from chronic diseases that are associated with a high incidence of iron deficiency and anemia.

Key Points: 
  • Many patient groups requiring home infusion therapies suffer from chronic diseases that are associated with a high incidence of iron deficiency and anemia.
  • For example, it is estimated that 40%-55% of all home parenteral nutrition patients are iron deficient.
  • We expect to finalize our Phase 2 clinical study design and protocol with the advice and guidance of the FDA.
  • Rockwell Medical expressly disclaims any obligation to update our forward-looking statements, except as may be required by law.

Global Anemia in Chronic Kidney Disease Analysis and Market Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Friday, June 4, 2021
Health, General Health, Medical specialties, Branches of biology, Clinical medicine, Growth factors, Mineral deficiencies, Anemias, Chronic kidney disease, Organ failure, Iron deficiency, Erythropoietin, Epoetin alfa, Roxadustat

The "Disease Analysis: Anemia in Chronic Kidney Disease" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Disease Analysis: Anemia in Chronic Kidney Disease" report has been added to ResearchAndMarkets.com's offering.
  • Biosimilars have also taken their toll, particularly in Europe, where biosimilar short-acting ESAs have taken a majority share of usage.
  • Iron is the other major anemia treatment, used for patients with iron deficiency from a potential multitude of causes associated with CKD.
  • Hence, they have the potential to take some market share from ESAs, as well as grow anemia treatment in non-dialysis CKD.

NaturesPlus Partners With Mediaplanet and Industry Leaders to Promote Better Blood Health

Retrieved on: 
Thursday, April 22, 2021
Mineral deficiencies, Iron deficiency

The campaign highlights the iron formulation HEMA-PLEX , made by NaturesPlus, which has changed the methodology for fighting iron deficiency by taking a holistic approach to improving blood health.

Key Points: 
  • The campaign highlights the iron formulation HEMA-PLEX , made by NaturesPlus, which has changed the methodology for fighting iron deficiency by taking a holistic approach to improving blood health.
  • *\nIron deficiency is the one of the common blood disorders, with nearly 10 million Americans suffering from its effects.
  • * "It is vitally important to choose the right supplement when you need iron," says NaturesPlus nutritionist Michela Vagnini.
  • To guarantee consistent quality, value, and results, NaturesPlus both manufactures and distributes its products for health and well-being.

Nemysis Ltd Establishes a New Subsidiary in the U.S.

Retrieved on: 
Wednesday, April 7, 2021
Blood, Branches of biology, Hematology, Mineral deficiencies, Iron metabolism, Anemias, Iron deficiency, Ferritin, Iron

We will bring innovative treatments to patients with nutritional deficiencies, and serve our existing and future principals in the best possible way.

Key Points: 
  • We will bring innovative treatments to patients with nutritional deficiencies, and serve our existing and future principals in the best possible way.
  • Zachary Dutton, CEO of Enteralia Bioscience added: "I am thrilled we are establishing Enteralia Bioscience LLC.
  • The U.S. and Boston area, in particular, is home to one of the most advanced scientific and medical communities.
  • Nemysis's novel nanoparticulate iron is the first natural ferritin mimic, which can correct human iron deficiency and anemia, without negatively impacting the gut microbiome.

Global $84 Billion Anemia and Other Blood Disorder Drugs Markets, 2015-2019, 2023F, 2025F, 2030F

Retrieved on: 
Friday, March 26, 2021
Blood, Hematology, Medical specialties, Hematopathology, Transfusion medicine, Anemias, Hematologic disease, Mineral deficiencies

Anemia and Other Blood Disorder Drugs Global Market Report 2020-30: COVID-19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global anemia and other blood disorder drugs market as it emerges from the COVID-19 shut down.

Key Points: 
  • Anemia and Other Blood Disorder Drugs Global Market Report 2020-30: COVID-19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global anemia and other blood disorder drugs market as it emerges from the COVID-19 shut down.
  • The anemia and other blood disorder drugs market consists of sales of anemia and other blood disorder drugs and related services.
  • Global Anemia And Other Blood Disorder Drugs Market, Segmentation By Anemia Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    5.1.
  • Global Anemia And Other Blood Disorder Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Global Anemia and Other Blood Disorder Drugs Market Report 2020-2030 Featuring Major Players - Amgen, GlaxoSmithKline, Akebia therapeutics, Bayer and Pfizer - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 24, 2021
Health, Pharmaceutical, Blood, Hematology, Medical specialties, Hematopathology, Anemias, Transfusion medicine, Hematologic disease, Mineral deficiencies

Anemia and Other Blood Disorder Drugs Global Market Report 2020-30: COVID-19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global anemia and other blood disorder drugs market as it emerges from the COVID-19 shut down.

Key Points: 
  • Anemia and Other Blood Disorder Drugs Global Market Report 2020-30: COVID-19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global anemia and other blood disorder drugs market as it emerges from the COVID-19 shut down.
  • The anemia and other blood disorder drugs market consists of sales of anemia and other blood disorder drugs and related services.
  • Global Anemia And Other Blood Disorder Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    5.2.
  • Global Anemia And Other Blood Disorder Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

CANADIAN HEALTH INNOVATORS, LUCKY IRON FISH ENTERPRISE, EXPAND THEIR PRESENCE IN MAINLAND CHINA

Retrieved on: 
Wednesday, March 3, 2021
Chemistry, Physical sciences, Natural sciences, Iron metabolism, Cast iron, Lucky iron fish, Mineral deficiencies, Iron deficiency, Physiological plant disorders, Iron

Toronto, ON, March 03, 2021 (GLOBE NEWSWIRE) -- Lucky Iron Fish Enterprise (LIFe) , a Canadian social enterprise that is committed to tackling iron deficiency, is pleased to announce that, after months of preparation, it has officially expanded its presence into Mainland China.

Key Points: 
  • Toronto, ON, March 03, 2021 (GLOBE NEWSWIRE) -- Lucky Iron Fish Enterprise (LIFe) , a Canadian social enterprise that is committed to tackling iron deficiency, is pleased to announce that, after months of preparation, it has officially expanded its presence into Mainland China.
  • LIFes simple cooking tools, Lucky Iron Fish and Lucky Iron Leaf, make it easy for families to enrich meals with a boost of natural iron for many years.
  • The company is currently selling its original product, Lucky Iron Fish, on Tmall Global but will be introducing its other product, the Lucky Iron Leaf , during phase two of the expansion.
  • Lucky Iron Fish is a clinically proven cooking tool that infuses meals with iron to help treat and prevent iron deficiency.

Worldwide IV and Oral Iron Drugs Industry to 2026 - Increasing Availability of Branded Iron Therapeutics and Expanded Indication Approvals Presents Opportunities

Retrieved on: 
Monday, February 22, 2021
Health, Chemistry, Physical sciences, Mineral deficiencies, Iron supplement, Iron deficiency, Iron, Compound annual growth rate

The global IV and oral iron drugs market by revenue is expected to grow at a CAGR of 11.6% during the period 2021-2026.

Key Points: 
  • The global IV and oral iron drugs market by revenue is expected to grow at a CAGR of 11.6% during the period 2021-2026.
  • The global IV and oral iron drugs market is expected to grow due to the prevalence of iron deficiency (ID).
  • What is the IV and oral iron drugs market size and growth rate during the forecast period?
  • 4. Who are the notable market players in the global IV and oral iron drugs market?